| Literature DB >> 29900230 |
Kevin M Rice1,2,3,4, Venkata Vinay Kumar Bandarupalli1, Nandini D P K Manne5, Eric R Blough1,3,6,7.
Abstract
Sepsis is a serious life threatening medical emergency which, if not treated properly, oftentimes results in organ failure and death. Current sepsis treatment protocols are largely centered on the use of antibiotics and supportive care. Recent studies have suggested that antibiotics fail to be effective for sepsis treatment when administered during hypo-dynamic phase of sepsis that is usually characterized by the presence of a cytokine storm. As such, there is an urgent need to develop novel therapeutic drugs that target the inflammatory cytokines that are secreted as a result of increased reactive oxygen species. Cerium oxide nanoparticles (CeO2) have been shown to act as anti-inflammatory and anti-oxidant agent. More recently, they have been shown to attenuate polymicrobial insult-induced mortality in Sprague Dawley rats. Here, we investigated whether CeO2 nanoparticles can attenuate splenic damage in this animal model of sepsis. A single intravenous dose (0.5 mg/kg) of CeO2 nanoparticles attenuated the sepsis-induced loss in splenic cell structural integrity. These improvements in splenic structure were accompanied by a decrease in expression of late phase pro-inflammatory cytokine high mobility group box 1 (HMGB1) along with reduced bacterial load in the blood and peritoneal fluid of septic animals. Taken together these findings suggest that CeO2 nanoparticles can be used to attenuate polymicrobial insult-induced splenic damage in Sprague dawley rats.Entities:
Keywords: CeO2 nanoparticles; Sepsis; Spleen
Year: 2018 PMID: 29900230 PMCID: PMC5996310 DOI: 10.1016/j.dib.2018.03.073
Source DB: PubMed Journal: Data Brief ISSN: 2352-3409
Fig. 1CeO2 nanoparticles attenuate severe sepsis induced inflammatory damage in spleen. A-D) Hematoxylin and eosin (H&E) staining of 3 h time point spleen sections imaged at 200× magnification - Control, CeO2, Sepsis, and Sepsis + CeO2. E-H) Hematoxylin and eosin (H&E) staining of 18 h time point spleen sections imaged at 200× magnification - Control, CeO2, Sepsis, and Sepsis + CeO2 (n = 3/group). Note: loss of white pulp in sepsis 18 h (arrow).
Fig. 2CeO2 nanoparticles attenuate severe sepsis induced increase in expression of pro-inflammatory cytokine HMGB1. Levels of HMGB1 at 3 h and 18 h in Control, CeO2, Sepsis, and Sepsis + CeO2 groups (n = 6/group).
Fig. 3Cecal inoculum method of polymicrobial sepsis does not induce caspase 3 mediated apoptosis in spleen. A) Total protein levels of Bax at 3 h and 18 h in Control, CeO2, Sepsis, and Sepsis + CeO2 groups. B) Levels of cleaved caspase 3 at 3 h and 18 h in Control, CeO2, Sepsis, and Sepsis + CeO2 groups. C) Total levels of caspase 3 at 3 h and 18 h in Control, CeO2, Sepsis, and Sepsis + CeO2 groups. (n = 6/group).
Fig. 4CeO2 nanoparticles attenuate bacterial load in blood and peritoneal fluid of septic animals. A) Bacterial load in blood. B) Bacterial load in peritoneal fluid.
| Subject area | Biology |
|---|---|
| More specific subject area | Nanomedicine |
| Type of data | Graph, figure |
| How data was acquired | Immunoblotting and histochemical analysis |
| Data format | Analyzed |
| Experimental factors | Rodent based intervention study examining the effects of cerium oxide nanoparticle treatment on sepsis. |
| Experimental features | Balanced design that encompasses both in vivo and in vitro observations. |
| Data source location | Huntington, WV USA |
| Data accessibility | Data is with this article and is related to articles published and in review |